Table: Brightpath Biotherapeutics - 9-MTH parent results

BrightPath Biotherapeutics Co

13/02/2026 06:43

Feb 13 (Reuters)- 
             Brightpath Biotherapeutics Co., Ltd. 
             PARENT-ONLY FINANCIAL HIGHLIGHTS 
     (in billions of yen unless specified)                
                 9 months ended      9 months ended        Year to  
                Dec 31, 2025        Dec 31, 2024      Mar 31, 2026  
                   LATEST             YEAR-AGO           LATEST     
                   RESULTS             RESULTS          FORECAST    
  Sales             0 mln               0 mln             0 mln     
                 (-62.5 pct)         (+33.3 pct)       (-87.6 pct)  
  Operating     loss 956 mln        loss 815 mln        loss 1.18   
  Recurring     loss 952 mln        loss 812 mln        loss 1.16   
  Net           loss 955 mln        loss 815 mln        loss 1.17   
  EPS           loss 9.07 yen      loss 10.30 yen    loss 12.88 yen 
  Ann Div                                NIL               NIL      
  -Q2 div            NIL                 NIL                        
  -Q4 div                                NIL               NIL      
  
  NOTE - Brightpath Biotherapeutics Co., Ltd.. 
  To see Company Overview page, click reuters://REALTIME/verb=CompanyData/ric=4594.T